Clinical trial
Optimal Insertion Time During Remimazolam-Remifentanil Anesthesia for Painless Gastroscopy: A Single-Center Randomized Controlled Trial
NCT07471893 is registered in ClinicalTrials.gov with Huizhou First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Insertion Time During Remimazolam-Remifentanil Anesthesia for Painless Gastroscopy: A Single-Center Randomized Controlled Trial
- Lead sponsor
- Huizhou First Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 8, 2024
- Completion date
- December 8, 2025
- Enrollment
- 342 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers